TPD52 Activators
TPD52 Activators encompass a variety of compounds that indirectly enhance the functional activity of TPD52, primarily through modulation of signaling pathways and alteration of cellular environments. Agents such as PMA function by activating Protein Kinase C (PKC). This activation influences the phosphorylation of proteins that interact with TPD52, thereby affecting its roles in cellular signaling and vesicle trafficking. Similarly, Epidermal Growth Factor (EGF) and Insulin activate their respective signaling pathways, leading to downstream effects that modulate TPD52's involvement in processes like cell proliferation, migration, and metabolic regulation. These signaling events demonstrate the intricate interplay between TPD52 and various cellular signaling cascades.
Furthermore, compounds such as Ionomycin and A23187 enhance TPD52 activity by increasing intracellular calcium levels. Elevated calcium impacts calcium-dependent signaling pathways, potentially influencing TPD52's function in diverse cellular processes. On the other hand, Forskolin, through its effect on increasing cAMP levels and activating PKA, and 1,2-Dioctanoyl-sn-glycerol, as a natural PKC activator, induce changes in the phosphorylation state of proteins that interact with TPD52, further elucidating the complex regulatory mechanisms of TPD52 activity. Additionally, Retinoic Acid, all trans and β-Estradiol, by modulating gene expression and signaling pathways, influence TPD52's involvement in cell differentiation, growth, and cancer cell dynamics. Tamoxifen, acting as an estrogen receptor modulator, also contributes to this modulation, particularly in estrogen-responsive pathways. Lastly, Lithium Chloride, by inhibiting GSK-3β, induces alterations in signaling pathways, impacting TPD52's function in neural processes. Collectively, these activators highlight TPD52's multifaceted role in cellular signaling and regulation, underscoring its significance in various physiological and pathological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA indirectly enhances TPD52 activity by activating Protein Kinase C (PKC). PKC activation can lead to the phosphorylation of proteins that interact with TPD52, influencing its function in cellular signaling and vesicle trafficking. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin indirectly enhances TPD52 activity by increasing intracellular calcium levels. Elevated calcium can modulate various calcium-dependent pathways, potentially influencing TPD52's function in cellular processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances TPD52 activity by increasing cAMP levels and activating PKA. This can lead to changes in the phosphorylation state of proteins interacting with TPD52, thereby influencing its function. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
1,2-Dioctanoyl-sn-glycerol indirectly enhances TPD52 activity as it is a natural activator of PKC. PKC activation can modulate TPD52's role in various cellular processes, including signaling and vesicle dynamics. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 indirectly enhances TPD52 activity by increasing intracellular calcium levels, thereby influencing calcium-dependent signaling pathways that can affect TPD52's function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans indirectly enhances TPD52 activity by modulating gene expression. This can influence TPD52's involvement in cell differentiation and growth processes. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin indirectly enhances TPD52 activity by activating insulin signaling pathways. This can lead to alterations in TPD52-related signaling pathways, influencing its role in metabolic processes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol indirectly enhances TPD52 activity by binding to estrogen receptors, which can modulate gene expression and signaling pathways involving TPD52, particularly in cancer cell proliferation and survival. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen indirectly enhances TPD52 activity by acting as an estrogen receptor modulator. This can affect estrogen-responsive pathways and thus influence TPD52's role in cellular processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride indirectly enhances TPD52 activity by inhibiting GSK-3β. This inhibition can lead to alterations in signaling pathways that modulate TPD52's function, particularly in neural processes. | ||||||